Why is "Agonists" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-15 11:22:19
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Agonists entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-03-15 and was most recently seen on 2026-03-15.
Wikipedia Overview
An agonist is a chemical that activates a receptor to produce a biological response. Receptors are cellular proteins whose activation causes the cell to modify what it is currently doing. In contrast, an antagonist blocks the action of the agonist, while an inverse agonist causes an action opposite to that of the agonist.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Potential of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Mitigating Metabolic Side Effects Associated With Clozapine or Olanzapine Therapy: A Literature Review - Cureus
-
GLP-1 RAs Show Survival and Cardiovascular Benefits in Patients With HFrEF and Diabetes - Cleveland Clinic
-
Could GLP-1 receptor agonists improve breast cancer outcomes for patients with obesity or type 2 diabetes? - Oncology Central
-
GLP-1 agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis | International Journal of Obesity - Nature
-
GLP-1 Receptor Agonists Show a Striking Signal in Breast Cancer Outcomes, but Big Questions Remain - Oncodaily
-
GLP-1 Receptor Agonists Linked to Improved Survival Outcomes in Breast Cancer - Pharmacy Times
-
Bariatric surgeon talks about the benefits, risks, misconceptions of GLP-1 Agonists - News4JAX
-
Editors’ Picks, April 2026: Immunotherapy-boosting Bacteria, GLP-1 Agonists for Breast Cancer Survivors, and More - American Association for Cancer Research (AACR)
-
Med14 phosphorylation shapes genomic response to GLP-1 agonists - PNAS
-
Inhibitory receptor agonists: Emerging strategies in immune modulation - Rockefeller University Press
-
GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits - The Lancet
-
Glucagon-like peptide-1 receptor agonists for major cardiovascular and kidney outcomes in type 1 diabetes - Nature
-
Agonists for cytosolic bacterial receptor ALPK1 induce antitumour immunity - Nature
-
ALPK1 agonists: a new strategy for cancer immunotherapy | Signal Transduction and Targeted Therapy - Nature
-
GTP release-selective agonists prolong opioid analgesic efficacy - Nature
-
Comprehensive evaluation of GLP-1 receptor agonists: an umbrella review of clinical outcomes across multiple diseases - Nature
-
Glucagon-like peptide 1 receptor agonists and cancer risk: the good, the bad and the unknown - Nature
-
Is addiction the next frontier for GLP-1 receptor agonists? - Nature
-
Genetic predictors of GLP1 receptor agonist weight loss and side effects - Nature
-
GLP-1 agonists and exercise: the future of lifestyle prioritization - Frontiers
-
Oral GLP-1 receptor agonists: competition for efficacy and tolerability - The Lancet
-
How do GLP-1 agonists affect gene expression? - Salk Institute for Biological Studies
-
Macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesity - Nature
-
New Data Suggest GLP-1 Receptor Agonists Slow Abdominal Aortic Aneurysm Progression - Cleveland Clinic
-
The expanding therapeutic landscape of GLP 1 receptor agonists - Nature
-
The effects of glucagon-like peptide-1 receptor agonists on sympathetic neuron activity - Nature
-
Cone snail venom-inspired somatostatin receptor 4 (SSTR - Nature
-
MTAP deficiency confers resistance to cytosolic nucleic acid sensing and STING agonists - Science | AAAS
-
Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139 - Nature
-
Cafestol-derivatives as potential FXR agonists and CYP7A1 inhibitors and their impact on hypercholesterolemia: an in silico study - Nature
-
Dual-Agonist Incretin Therapy Outshines GLP-1 Agonist in Broad Cardiorenal Outcomes - Cleveland Clinic
-
GLP-1s For Treatment of Alcohol Use Disorder: Current and Future Directions - Psychiatric Times
-
Engineering synthetic agonists for targeted activation of Notch signaling - Nature
-
STING agonists trigger monocyte death via apoptosis, pyroptosis, caspase-8 activation and mitochondrial dysfunction - Nature
-
GLP-1 Receptor Agonists and Research to Treat Overeating and Substance Use Disorders - Journal of Neuroscience
-
Do GLP-1 Medications Improve Breast Cancer Survival? - Cancer Health
-
Glucagon-like peptide-1 agonists’ effects on glycemic control, weight loss, and beta cells function in type 1 diabetes - Frontiers
-
First orexin agonists address root cause of narcolepsy - Nature
-
Perspectives from employers on the costs and issues associated with covering GLP-1 agonists for weight loss - healthsystemtracker.org
-
Reconciling GLP-1s and Pancreatitis - Cleveland Clinic
-
Selective agonists of KIR and NKG2A to evade missing self response of natural killer cells - Nature
-
Glucagon-like peptide-1 receptor agonists in arthritis: current insights and future directions - Nature
-
Integrative gene-metabolite network analysis of GLP-1 receptor agonists and related incretin pathways in cardiometabolic health - Nature
-
Ovarian Protection With GnRH Agonists During Chemotherapy: Moving From Evidence to Routine Practice - ASCO Daily News
-
Neoadjuvant Glucagon-Like Peptide-1 Receptor Agonists in Abdominal Wall Hernia Surgery: A Narrative Review - Wiley Online Library
-
GLP-1 Receptor Agonists Protect the Liver During Alcohol Consumption - Yale School of Medicine
-
Could GLP-1 drugs help breast cancer patients live longer? - News-Medical
-
GLP-1 receptor agonists: exploration of transformation from metabolic regulation to multi-organ therapy - Frontiers
-
Comparative Outcomes of GLP-1 Receptor Agonists vs Bariatric Surgery in Patients Undergoing Atrial Fibrillation Ablation - JACC Journals
-
Possible mechanisms of action of glucagon-like peptide-1 receptor agonists on blood pressure beyond body weight - Nature
-
Synthetic GLP-1s' popularity is growing and so is their influence on the market - Quiver Quantitative
-
Beta-2 Agonists Erectile Dysfunction: What the Evidence Actually Shows for Metabolic and Performance Support - stat.gov.pl
-
GLP-1 agonists may interfere with cancer imaging, new study finds - healthcare-in-europe.com
-
Discovery of a small molecule TLR3 agonist adjuvant - Nature
-
GLP-1 Receptor Agonists Show Potential Relative Reduction in CRC Incidence Compared With Aspirin - ASCO Daily News
-
What do GLP-1 receptor agonists actually do? - VCU Health
-
ECO 2026: tirzepatide shows potential for T1D treatment - Pharmaceutical Technology
-
Rational Design of DNA Nanostructures as TLR9 Agonists - ACS Publications
-
SCALE 2026: GLP-1 Weight Loss Intensifies Aesthetic Care - EMJ
-
GLP-1 Drug Makes Its Case for Treating Plaque Psoriasis - MedPage Today
-
GLP-1 Drug Linked to Cases of Rare Vision-Altering Condition - MedPage Today
-
New obesity medications offer a potent tool for combating hypertension - News-Medical
-
Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes - investor.lilly.com
-
Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial | Eli Lilly and Company - investor.lilly.com
-
Effects of GLP-1 Receptor Agonists vs Metformin in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis - Cureus
-
Soluble Notch agonists drive T cell production - Nature
-
How Do GLP-1 Agonists Fit Into Stroke Care? - AJMC
-
Perspectives from Employers on the Costs and Issues Associated with Covering GLP-1 Agonists for Weight Loss - KFF
-
Activation of CD40 in tumors reprograms the tumor microenvironment - Nature
-
Tumour-specific STING agonist synthesis via a two-component prodrug system - Nature
-
WHO issues global guideline on the use of GLP-1 medicines in treating obesity - World Health Organization (WHO)
-
Association Between GLP-1 Receptor Agonist Use and Epilepsy Risk in Type 2 Diabetes - Neurology® Journals
-
Ozempic for Arthritis? GLP-1 Agonists Show Promise in Easing Symptoms in Obese Patients - CU Anschutz newsroom
-
How does the new obesity treatment drug 'Retatrutide' avoid the pitfalls of GLP-1 receptor agonists? - GIGAZINE
-
GLP-1 Receptor Agonists May Improve Rheumatoid Arthritis Symptoms - AJMC
-
Study on GLP-1s and Breast Cancer 'Too Good to Be True'? - MedPage Today
-
Can amylin-based drugs upstage GLP-1 agonists? - Nature
-
Unlocking the potential of GLP-1 receptor agonists in ocular therapeutics: from molecular pathways to clinical impact - Frontiers
-
‘Encouraging’ signal: GLP-1s may help reduce breast cancer recurrence, improve survival - Healio
-
Restless legs syndrome treatment — gabapentinoids or dopamine agonists? - Via Medica Journals
-
Fluorescent GLP1R/GIPR dual agonist probes reveal cell targets in the pancreas and brain - Nature
-
WHO’s new guidance on maintaining opioid agonist maintenance treatment as an essential health service - World Health Organization (WHO)
-
GLP-1 weight loss medications linked to significant drop in asthma flares - News-Medical
-
PPARγ Agonists Accelerate MRI Signal Resolution Mediated by Resting-State Astroglia in Acute Intracerebral Hemorrhage - American Heart Association Journals
-
Malnutrition with use of GLP-1 agonists is an underestimated real world harm - The BMJ
-
Dopamine Agonists and Erectile Dysfunction: What the Evidence Shows for Men Exploring Support Options - stat.gov.pl
-
Beta-2 Agonists and Erectile Dysfunction: What the Evidence Shows and Practical Considerations - Portal CNJ
-
Beta 2 Agonists Erectile Dysfunction: Exploring the Links and Supplement Options - stat.gov.pl
-
Kefah Mokbel: GLP-1 Drugs Show Promise in Breast Cancer - Oncodaily
-
Deciphering highly potent natural abscisic acid agonists for binding to pyrabactin resistance 1 receptor through computational approaches - Nature
-
Nitazene Opioids: Are They Safer Than Traditional Opioids? - MedCentral
-
Beta-2 agonists and erectile dysfunction - Portal CNJ
-
Dopamine agonists and erectile dysfunction - Portal CNJ
-
Dopamine Agonists and Erectile Dysfunction: Exploring the Connection and Natural Support Options - Portal CNJ
-
Dopamine Agonists and Erectile Dysfunction: What the Evidence Shows and Practical Considerations - Portal CNJ
-
GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation - Frontiers
-
Erectile Dysfunction Dopamine Agonists: What They Are and How They Fit Into Men's Health - Portal CNJ
-
GLP-1 Diabetes Treatment Drugs Market Forecast to 2035: Growth Driven by Oral Formulations and Cardiovascular Indications - News and Statistics - IndexBox
-
Dopamine agonists and erectile dysfunction - Portal CNJ
-
Beta 2 Agonists Erectile Dysfunction: What the Evidence Actually Shows for Supplement Users - Portal CNJ
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.